ISTH 2021 Congress Archives - ISTH Congress Abstracts

Abstract Number: PB1040

A 3D in vitro Model of Inflammation-associated Bleeding

R. Riddle¹, K. Hansson², K. Jennbacken², M. Harper¹
Abstract Number: PB0784

A 5-Year Study of Arterial and Venous Thromboses in Greek Infants, Children and Adolescents. Comparison of Data Before and during the Pandemic Period

L. Ioannidou¹, A. Dettoraki¹, A. Michalopoulou¹, Z. Kapsimali¹, S. Saslis¹, M. Mazarakis¹, H. Pergantou¹
Abstract Number: PB0624

A Bleed Suppression Efficacy of Emicizumab in Patients with Hemophilia A whose Therapies Switched from Conventional Prophylaxis

T. Fujii¹, N. Yamasaki¹, T. Inoue¹, T. Fujii¹
Abstract Number: OC 48.1

A Blood Coagulation Factor IX Variant that Functions Independently of Factor VIII Mitigates the Hemophilia A Phenotype in Patient Plasma

V.J. Strijbis¹, L.G. Romano², K.L. Cheung¹, Y.P. Liu³, A.C. McCreary³, F.W. Leebeek², M.H. Bos¹
Abstract Number: PB0807

A Case of a Pediatric Patient with Protein S Heerlen Polymorphism and Deep Venous Thrombosis

M. Kacar¹, M. Bhatt¹
Abstract Number: PB0408

A Case of Congenital Afibrinogenemia with Two Successful Spontaneous Delivery After Recurrent Pregnancy Losses

M. Mastanzade¹, M.M. Özbalak¹, S. Kalayoğlu Beşışık¹
Abstract Number: PO117

A Case of Recurrent Myocardial Infarction and Heterozygous Factor V Leiden

E. Grinsztejn¹, J.P. Dugan¹, E.X. Stavrou^2,3
Abstract Number: PB0812

A Case Report and Comprehensive Review of Acquired Purpura Fulminans in Children

S. Zarb¹, A.K. Chan², V. Price³, M.D Bhatt²
Abstract Number: PB1072

A Comparative Cohort Study of Serum Rivaroxaban Levels in Singaporean (SG) and British (UK) Non-valvular Atrial Fibrillation (NVAF) Patients

E.X. Yong¹, Y.Y. Lin², D. Tan¹, E. Chan¹, V. Speed³, J. Patel³, E.S. Yap⁴, G. Chang², P. Gallagher¹
Abstract Number: PB0080

A Comparative Study of SEER Sonorheometry versus Thromboelastography during Cardiac Surgery with Cardiopulmonary Bypass

A. Abbes¹, C. Frere^1,2, J. Loeb¹, N. Djavidi¹, G. Lebreton^1,2, A. Bougle^1,3
Abstract Number: PB0984

A comparison of Five Platelet Reactivity Tests in Over 3,000 Participants of the Framingham Heart Study

M.V. Chan¹, M.-H. Chen¹, F. Thibord¹, A. Lachapelle¹, J. Grech¹, P.C.J. Armstrong², T.D. Warner², A.D. Johnson¹
Abstract Number: PB0364

A Comparison of Functional Methods with Absolute Quantification of Heparin Levels in Clinical Samples by Heparin Red Assay

E. Bontekoe¹, F. Siddiqui¹, D. Hoppensteadt¹, A. Kouta¹, J. Fareed¹, R. Kraemer²
Abstract Number: PB1073

A Comparison of the Incidence of Traumatic Brain Injury in Anticoagulated and Non-anticoagulated Head Injured Patients

F. Al-Haimus¹, N. Clayton^1,2, J. Klyn², K. de Wit^3,1
Abstract Number: PB0810

A Comprehensive Review of Tumour Thrombus in Pediatric Wilms Tumour Patients

K. Kwok¹, A.K. Chan¹, M.D Bhatt¹, N. Samji¹
Abstract Number: PB0781

A Conservative Therapy Spontaneous Intracranial Hemorrhage in a Pediatric Patient with Severe Acquired Aplastic Anemia

M.-M. Deveza¹, A. Rodrigues¹, T. Quaresma¹, C. Peixoto¹, A. Ferrão²
Abstract Number: PB0003

A Coupled 1D-3D Hybrid Model for Patient-specific Coronary Flow Simulations: Bridging the Gap between Macroscale Hemodynamics and Microscale Thrombosis Models

N. Grande Gutierrez¹, T. Sinno¹, S. Diamond¹
Abstract Number: PB1057

A Diagnostic Solution for Lupus Anticoagulant Testing in Patients Taking Direct Oral FXa Inhibitors Using DOAC Filter

C. Farkh¹, S. Ellouze¹, L. Gounelle¹, M. Sad-Houari¹, J. Duchemin¹, V. Proulle¹, M. Fontenay^1,2, X. Delavenne^3,4, G. Jourdi^1,5,6,7
Abstract Number: OC 74.2

A Heterozygous Mutation in SLFN14 Influences Species-specific Haematopoietic Regulation in Platelet and Erythroid Lineages

R. Stapley¹, C. Smith¹, E. Haining¹, A. Bacon², S. Lax³, V. Pisareva⁴, A. Pisarev⁴, S. Watson^1,5, A. Khan¹, N. Morgan¹
Abstract Number: PB0002

A Machine-learning-Based Bio-psycho-Social Model for the Prediction of Non-obstructive and Obstructive Coronary Artery Disease

V. Raparelli¹, M. Proietti², G.F. Romiti³, R. Seccia⁴, G. Di Teodoro⁴, G. Tanzilli⁵, R. Marrapodi³, B. Corica³, D. Flego³, R. Cangemi³, L. Palagi⁴, S. Basili³, L. Stefanini³
Abstract Number: PB1287

A Major Knowledge Gap in Women’s Health: The Combined Effect of Antifibrinolytics and Estrogen on Risk of Thromboembolism – A Scoping Review

D. Meschino^1,2, D. Lindsay^2,3, G. Tang^2,1,4, P. James^5,6, M. Sholzberg^2,1,4
Abstract Number: OC 35.4

A Major Reservoir for Heparin-releasable TFPIα is Extracellular Matrix

J. Peterson¹, S. Maroney¹, N. Martinez¹, A. Mast¹
Abstract Number: OC 54.1

A Mechanism for Hereditary Angioedema Caused by a plasminogen Lys311Glu Substitution

SK. Dickeson¹, S. Kumar¹, M.-F. Sun¹, B.M Mohammed¹, Q. Cheng¹, I. Ivanov¹, J.C Whisstock², A.J Quek³, E.P Feener⁴, D.R Phillips⁵, R.HP Law², D. Gailani¹
Abstract Number: OC 16.4

A Mouse Model of Protease Activated Receptor 4 (PAR4) variant rs2227376 Has Reduced Platelet Reactivity to Physiological Doses of Thrombin

X. Han¹, M. de la Fuente¹, E. Knauss¹, M. Nieman¹
Abstract Number: PB1230

A Multi-disciplinary Approach to Improving Temporary IVC Filter Retrieval Rates

J. Kamp¹, T. Ammar¹, J. Wilkins¹, L. Roberts¹
Abstract Number: PB0821

A Multicenter Double-blind, Double-dummy, Randomized Study of rhTPO vs Eltrombopag in the Treatment of Chinese Immune Thrombocytopenia

H. Mei¹, M. Xu¹, G. Yuan², F. Zhu³, J. Guo⁴, R. Huang⁵, J. Qin⁶, T. Lv², F. Qin³, H. Cai⁴, P. Yin⁷, T. Qin⁷, Y. Hu¹
Abstract Number: PB0857

A Multicenter Retrospective Evaluation of Direct Oral Anticoagulants for the Treatment of Heparin Induced Thrombocytopenia

K. Davis¹, J. Sebaaly², L. Wooten³, C. Khouli⁴, A. Mihm¹, S. Nisly^1,5
Abstract Number: LPB0130

A Multiscale Framework for Patient-specific Predictions of Thrombus Growth

K. Shankar¹, T. Sinno¹, S. Diamond¹
Abstract Number: PB1286

A New Pharmacodynamic Test to Evaluate Effects of Oral Contraceptives on Coagulation

P. de Kruijf¹, S. Naji¹, C. Krijnen¹, J. Jespersen², C. Kluft¹
Abstract Number: PB0904

A Novel Disease-causing Variant in the GP1BA Gene Related to Bernard Soulier Syndrome

A.I. Woods¹, M.F. Alberto², D.M. Primrose³, J. Paiva⁴, M. Asencio⁴, M.M. Casinelli⁴, A.N Blanco⁴, A. Sánchez-Luceros^4,5
Abstract Number: PB0880

A Novel Dual AntiPlatelet and AntiCoagulant APAC: Interaction Between Platelet Factor 4 (PF4) and APAC Decreases Functional Activity

I. Nevzorov¹, A. Jouppila², R. Lassila^3,4
Abstract Number: PB1055

A Novel ELISA Assay for the Detection of Anti-prothrombin Antibodies in APS Patients at High Risk of Thrombosis

N. Pozzi¹, V. Pengo²
Abstract Number: PB0896

A Novel Hemizygous Variant in GATA1 Associated with Bleeding Diathesis and Platelet Dysfunction in Two Unrelated Patients

J.M. Bastida^1,2,3,4, D. Boeckelmann^5,6, V. Palma-Barqueros^7,8, M. Wolter^5,6, M.L Lozano^7,8, H. Glonnegger^5,6, R. Benito^2,3, F.H Schilling⁹, N. Morgan¹⁰, K. Freson¹¹, J. Rivera^7,8,4, B. Zieger^5,6
Abstract Number: PB0029

A Novel Mouse Model for Cerebral Venous Thrombosis

M.-C. Bourrienne¹, S. Loyau¹, S. Benichi², J. Gay¹, M. Solo-Nomenjanahary¹, D. Faille^1,3, C. Journé⁴, L. Di Meglio¹, A. Freiherr von Seckendorff¹, J.-P. Desilles^1,5, B. Ho-Tin-Noé¹, M. Mazighi^1,5,6, N. Ajzenberg^1,3
Abstract Number: PB0342

A Novel Paper-based Test for Diagnostic of Fibrinogen Levels on Whole Blood

A.T. Sachetto¹, N.T. Picon², C.B. Morgado², M. L. Santoro¹
Abstract Number: OC 61.3

A Novel Particle-based Model Delivers Mechanistic Insights into Arterial Thrombus Heterogeneity

A.A. Masalceva^1,2, V.N. Kaneva^1,2,3, M.A. Panteleev^1,2,3,4, F.I. Ataullahanov^1,2,3,4, V. Volpert^5,6,7, I.V. Afanasyev^8,9, D.Y. Nechipurenko^1,2,3
Abstract Number: OC 05.3

A Novel Prediction Platform to Enhance the Design of Therapeutic SERPINs

W. Sanrattana¹, T. Sefiane², S. Smits¹, M. Fens³, D. Monroe⁴, P. Lenting², C. Maas¹, S. de Maat¹
Abstract Number: PB0650

A Novel Strategy for Platelet-specific Gene Therapy for the Treatment of Hemophilia A via Intranasal Delivery Lentiviral Vectors Containing Factor VIII

C.W. Rementer¹, C. Li¹, C.-Y. Chen¹, C.H. Miao¹
Abstract Number: PB0971

A Novel Therapeutic Strategy for Hepatocellular Carcinoma Based on the Tumor-platelet Interaction

H. Tanaka¹, K. Horioka²
Abstract Number: PB0402

A Patient with Congenital Hypofibrinogenemia who Showed Embryo Implantation, Continuation of Pregnancy, and Delivery Following Continuous Transfusion of Dry Human Fibrinogen Preparations

Y. Seki¹, T. Ushiki², M. Masuko³, J. Takizawa³, H. Sone³, N. Okumura⁴
Abstract Number: PB1121

A Population-Based Descriptive Study of Long-term Anticoagulation in the Treatment and Secondary Prophylaxis of Venous Thromboembolism in Men with Prostate Cancer in Sweden

Y. Balabanova¹, B. Farahmand², P. Stattin³, H. Garmo³, G. Brobert²
Abstract Number: PB1155

A Potential Risk of Venous Thrombosis Induced by Nanomaterials and the Protection Role of Nrf2

Y. Bian^1,2, J. Pi¹
Abstract Number: PB1068

A Prolonged Actived Partial Thromboplastin Time Revealing a Childhood Systemic Lupus erythematosus

I. Krichen¹, S. Samet¹, F. Megdich¹, M. Hsairi², L. Gargouri², A. Mahfoudh², C. Kallel¹
Abstract Number: PB0640

A Prospective Cohort Study on Disabilities in Patients with Haemophilia Using Orthopaedic Scores

M. Bajracharya¹, B.S. Poudyal¹, S. Marahatta¹, S. Rayamajhi¹, V. Prajapati¹, C.D.K. Mahato¹
Abstract Number: PB0450

A Prospective Comparison Study of the Diagnosis of Disseminated Intravascular Coagulation (DIC) Comparing Between ISTH DIC Scoring system and General Practice in Prediction of 28-day Mortality

T. Thamgrang¹, C. Sirisuksakun¹, K. Prayongratana¹
Abstract Number: PB0806

A Prospective Data Collection Utilizing the International Pediatric Thrombosis Network (IPTN) to Understand the Epidemiology for the Development of Neonatal Renal Vein Thrombosis

G. Woods¹, J. Motwani², N. Sirachainan³, R. Berrueco⁴, C.H. van Ommen⁵, A.KC Chan⁶
Abstract Number: PB0863

A Puzzling HIT History: HIT Associated with Fondaparinux or True Autoimmune HIT?

N. Sillamy¹, C. Vayne^1,2, J. Rollin^1,2, M. Desailly¹, M. Navarro³, J.-B. Valentin¹, C. Pouplard^1,2, Y. Gruel^1,2
Abstract Number: PB0586

A Qualitative Study on the Experiences of Hemophilia Carriers before, during and after Pregnancy

M.C. Punt¹, L. Teela², K. Fischer¹, K.W.M. Bloemenkamp³, A.T. Lely³, M.H.E. Driessens⁴, L. Pekel⁴, L. Haverman², K.P.M. van Galen¹.
Abstract Number: PB0933

A Quantitative Evaluation of vWF Multimeric Structure in Patients with Different Types of vWD and aVWS

A. Poletaev¹, E. Seregina^1,2, N. Karamyan¹, P. Zharkov¹
Abstract Number: OC 60.1

A Randomized, Double-blind, Placebo-controlled, Phase 2 Study Evaluating Safety and Efficacy of AB023 in Hemodialysis Patients

C. Lorentz^1,2, E.I. Tucker^1,2, N.G. Verbout^1,2, J.J. Shatzel², S.R. Olson², B.D. Markway¹, M. Wallisch^1,2, M. Ralle², M.T. Hinds², O.J. McCarty², D. Gailani³, J.I. Weitz⁴, A. Gruber^1,2
Abstract Number: PO165

A Rare Case of Bi-atrial Thrombi in a Stage IV Pancreatic Cancer Patient with Atrial Fibrillation on Warfarin

K.Y. Kim¹, N.H. Kim¹, T. Alrifai²
Abstract Number: PB0801

A Rare Case of Thrombotic Storm in Henoch-Schonlein Purpura

A.K. Baylon¹, H.P. Tan¹, M.L. Naranjo¹, C. Fernandez¹, R. Anastacio¹, C.R. Castro¹
Abstract Number: PB0005

A Rare Presentation of ST-segment Elevation Myocardial Infarction Associated with Ovarian Stimulation in the Absence of Ovarian Hyperstimulation Syndrome

K.Y. Kim¹, Y. Gerais¹, A. Prasad¹, N.H. Kim¹, C. Sun¹, S. Hussein¹, P. Thapa¹, R. Ramadurai²
Abstract Number: PB1256

A Real-world Experience of Venous Thromboembolism (VTE) Management in Australia

B. Lui¹, A. Kwok², J. Lai², Z. Khattak¹, P. Ho¹, H.Y. Lim^1,2
Abstract Number: PB1272

A Realist Evaluation on Therapeutic Elastic Compression Therapy Pathways for DVT- and CVD Patients to Develop Evidence-informed Improvement Strategies

R.H. Schreurs^1,2,3, M.A. Joore⁴, D. De Bruijn-Geraets⁴, H. Ten Cate^1,2,3, A.J. Ten Cate-Hoek^1,2
Abstract Number: PO156

A Refractory Thrombotic Thrombocytopenic Purpura Case Complicated by Hepatic Sinusoidal Obstruction Syndrome and Successful Management with Defibrotide

S. Erdem¹, M. Mastanzade¹, S. Altay-Dadin², M. Yanasik³, S. Kalayoglu-Besisik¹
Abstract Number: PB1249

A Retrospective Evaluation of the Management of Isolated Distal Deep Vein Thrombosis in Australia

B. Lui¹, J. Lai², Z. Khattak¹, A. Kwok², P. Ho¹, H.Y. Lim^1,2
Abstract Number: PB0776

A Retrospective Review of Diagnosis and Management of Heavy Menstrual Bleeding and Co-morbidities in Patients Seen in Young Women’s Blood Clinic

D. Desai¹, M. Joshi¹, R. Upadhyay¹, D. Costescu¹, M. Bhatt¹
Abstract Number: PB0491

A Review Following Implemented Training for Health Care Practitioners in Primary Care Settings of Immunisation Practice in Children with Bleeding Disorders

M. Eales¹, A. Wilkinson¹, S. Pool², G.W Hall¹, N. Bhatnagar¹
Abstract Number: PB0703

A Review of Beighton Scores Recorded for All Patients with a Bleeding Tendency Registered at One Haemophilia Centre without Another Formal Bleeding Disorder Diagnosis

J. Clark¹, D. Stephensen¹, C. Dodd¹, K. Elliott¹
Abstract Number: PB0751

A Role of Possible Synergistic Effect of P Selectin Glycoprotein Ligand 1 Polymorphism and Antiphosholipid Antibodies on Thrombosis in Myeloproliferative Neoplasia Patients

R. Dambrauskienė¹, R. Gerbutavičius¹, R. Vadeikienė¹, R. Gerbutavičius², R. Ugenskienė¹, M. Rudžianskienė¹, E. Juozaitytė¹, D. Remeikienė¹, R. Gerbutavičienė³, R. Paukštaitienė⁴
Abstract Number: PB1025

A rRle for the JAK/STAT5 Axis in GPVI-mediated Platelet Function

I. Parra Izquierdo¹, A. R. Melrose¹, J. Pang¹, S.H. Vasilipalli¹, S. E. Reistma¹, H.H. Sudhan Lakshmanan¹, M. K. Larson², O. J.T. McCarty¹, J. E. Aslan¹
Abstract Number: PB0663

A Savvy Approach to Clinical Trial Recruitment for the SAAVY (Seroprevalence of AAV AntibodY) Study in the Era of COVID-19: Designing for a Prospective, Observational Study in the United States during a Global Pandemic

L.A. Valentino¹, M. Vaghela², M. Lauw², G. Dela Cerda², M. Jones², D. Hinds², V. Newman², F. Leal-Pardinas², D. Rotellini¹, K. Schafer³, G. Pierce⁴, S. Pipe^5,6
Abstract Number: PB0321

A Service Evaluation of Prothrombin Complex Concentrate Use and Safe Administration Procedures in a Tertiary Hospital and Trauma Centre

M. Robinson¹, C. Hickman¹
Abstract Number: LPB0098

A Simple Score to Evaluate Bleeding Risk in Medical Patients Taking Antiplatelets for Cardiovascular Prevention

S. Barbar¹, A. Vecchiato², F. Moro², F. Boscaro², F. Fabris²
Abstract Number: PB1182

A Simplified Decision Rule to Rule out Deep Vein Thrombosis Using Clinical Assessment and D-dimer

K. Xu¹, K. de Wit^2,3, G.-J. Geersing⁴, T. Takada⁴, R. Schutgens⁴, J. Elf⁵, C. Kearon^2,3, S. Parpia^6,7.
Abstract Number: PB0533

A single center study of bone mineral density in adult patients with severe Haemophilia A and correlation with markers of bone metabolism

H. Ivanova¹, Z. Grudeva-Popova¹, T. Deneva¹, N. Mateva^2,2
Abstract Number: OC 14.2

A Single-domain Antibody Anti-protein Z Dependent Protease Inhibitor Improves Thrombin Generation in Hemophilia

C. Auditeau¹, T.S. Nguyen¹, C. Repérant¹, S. Daramé¹, F. Saller¹, D. Borgel^1,2, E. Bianchini¹
Abstract Number: LB 01.3

A Six-week versus Three-month Duration of Anticoagulation for Acute Provoked Venous Thromboembolism in Patients < 21 Years Old: Results of the Multinational Kids-DOTT Randomized Controlled Trial

N.A. Goldenberg¹,², S. Schulman³, J.M. Kittelson⁴, T.C. Abshire⁵,⁶, M. Bonaca⁴,⁷, J.F. Casella⁸, R.A. Dale⁷, J.L. Halperin⁹, F. Hamblin², C.M. Kessler¹0,¹¹, M.J. Manco-Johnson⁴, R.F. Sidonio¹²,¹³, A.C. Spyropoulos¹⁴,¹⁵,¹⁶, P.G. Steg¹⁷, A.G.G. Turpie³, W.R. Hiatt⁴,⁷, Kids-DOTT Trial Investigators§ and the ATLAS Group
Abstract Number: PB0628

A Study of Psychosocial Issues for Mothers of Children with Hemophilia

A. Nakao¹, J. Yamanouchi¹
Abstract Number: PB1270

A Survey of Current Anticoagulation Patient Education Practices and Development

A. Jones¹, J. Saunders², S. Vazquez³, A. Fagerlin¹, D. Witt²
Abstract Number: PB0367

A Systematic Review and Meta-analysis of Performances of Prototype and Commercial DOAC Dipstick Tests for Detecting Direct Oral Anticoagulants in Patient Urine Samples – Increasing Confidence for Testing in Emergency Care

A. Martini¹, R. Bauersachs², J. Beyer Westendorf³, M. Crowther⁴, J. Douxfils^5,6, I. Elalamy⁷, J. Harenberg^8,9, S. Hetjens¹, C. Weiss¹
Abstract Number: PB1223

A Systematic Review and Meta-analysis on the Use of Chemoprophylaxis in the Prevention of Venous Thromboembolism in Colorectal Cancer Surgery in Asian Population

S.J.J. Tan¹, A.Y. Chok¹, Y.Y. Ng¹, I. Seow-En¹, R. Sultana², J.C. Allen², E.K.W. Tan¹, R. Mathew¹.
Abstract Number: PB0682

A Systematic Review on the Pharmacokinetics and Associated Pharmacodynamics of Emicizumab in Humans

A. Donners¹, C. Rademaker¹, L. Bevers¹, A. Huitema^1,2,3, R. Schutgens¹, A. Egberts^1,4, K. Fischer¹
Abstract Number: OC 47.2

A Thrombospondin-1 Release Assay (TRA) Coupled to PF4-treated Frozen Platelets is Highly Accurate for the Detection of Pathogenic HIT Antibodies: Implications for Development of a Near-patient HIT in vitro Diagnostic Assay

A. Padmanabhan¹, B. Singh¹, C. Jones², R. Leger¹, R. Pruthi¹, N. Heikal¹, D. Chen¹
Abstract Number: OC 27.4

A Unique Loop Structure in the A2-domain of Pseudonaja textilis Factor Va Prevents Activated Protein C-catalyzed A2-domain Dissociation

M. Schreuder^1,2, X. Liu³, K.L. Cheung¹, P.H. Reitsma^1,4, G.A.F. Nicolaes³, M.H.A. Bos¹
Abstract Number: PB0186

A Weight-based Approach to Thromboprophylaxis Dosing for Medical Inpatients with COVID-19

R. Price¹, Z. Kirkham^1,2, A. Szuman¹, S. Ahmed³, C. Macaulay⁴, K. Talks⁵, B. Greystoke⁵, K. Musgrave^2,5
Abstract Number: OC 75.4

AAV Delivery of a Novel Human Factor VIII Variant with Improved Secretion Results in Higher FVIII Expression in Hemophilia A Dogs

G. Nguyen¹, E. Merricks², T. Long², K. Ponder³, T. Nichols², D. Sabatino¹
Abstract Number: OC 69.3

Abdominal Thromboses in Pediatric Patients: What Do we Know?

S. Kuldanek¹, A. Chan¹, D. Thornhill¹, L. Jacobson¹, C. Baird¹, J. Smith¹, R. Shearer¹, M. Manco-Johnson^1,1
Abstract Number: LB 01.2

Abelacimab for Prevention of Venous Thromboembolism

P. Verhamme¹, A. Yi², A. Segers³, J. Salter², D. Bloomfield², H. Buller⁴, G. Raskob⁵, J. Weitz⁶
Abstract Number: PB0954

Aberrant Expression of Lnc-MEG3 and Lnc-NOTCH1 Predicts Refractory Phenotype in Chronic Idiopathic Thrombocytopenic Purpura

N. El-Khazragy^1,2, S. Matbouly³, H.F. Abdelsamee⁴
Abstract Number: PB0095

Ability of Fibrin Monomers and Fibrinogen Levels to Predict In-hospital Mortality in Patients with Severe Trauma

T. Nguyen¹, N. Tran², T. Tran², D. Nguyen¹, N. Thang¹, T. Nguyen¹, T. Tran¹
Abstract Number: PB1153

Abnormal Thrombin Generation in Children with Thrombosis

S. Kuldanek¹, D. Thornhill¹, L. Jacobson¹, C. Baird¹, A. Chan¹, J. Smith¹, R. Shearer¹, M. Manco-Johnson¹
Abstract Number: PB1141

ABO Blood Groups as a Risk Factor for the Development of Deep Vein Thrombosis of the Lower Extremities in Elderly and Senile Patients

A. Tomchenko¹, A. Chechulova¹, V. Soroka¹, S. Nokhrin¹, I. Khomchuk¹
Abstract Number: LPB0099

Absence of CCR5/CCL5 Axis Inhibits Thrombus Resolution through Reduced uPA, tPA and VEGF Expressions in DVT Model

M. Nosaka¹, Y. Ishida¹, A. Ishigami¹, Y. Kuninaka¹, H. Yamamoto¹, E. Shimada¹, Y. Hashizume¹, M. Kawaguchi¹, A. Kimura¹, N. Mukaida², T. Kondo¹.
Abstract Number: PB0032

Absolute Measurement of Bovine and Porcine Heparin Red Assay Utilizing the Heparin Red Assay. Applications in the Study of Pharmacokinetics and Pharmacodynamics

W. Jeske¹, A. Kouta¹, D. Hoppensteadt¹, L. Cera¹, R. Duff¹, J. Fareed¹, R. Kraemer²
Abstract Number: PB1081

Accounting of Symptoms and Ejection Fraction May Improve Prediction of Left Atrial Thrombus in Patients with Non-valvular Atrial Fibrillation before Catheter Ablation or Cardioversion

I. Zaigraev¹, I. Yavelov¹, O. Drapkina¹, E. Bazaeva¹
Abstract Number: PB0190

ACE2, ACE and Thromboinflammation in COVID-19

A. Lundström¹, L. Ziegler¹, S. Havervall¹, A.-S. Rudberg¹, F. Von Meijenfeldt², T. Lisman², N. Mackman³, P. Sandén¹, C. Thålin¹
Abstract Number: PB1026

Acetyl-CoA Carboxylase Inhibition Alters Tubulin Acetylation and Aggregation in Thrombin-stimulated Platelets

M. Octave¹, L. Pirotton¹, A. Ginion¹, V. Robaux¹, S. Lepropre¹, S. Kautbally¹, V. Darley-Usmar², J. Ambroise³, B. Guigas⁴, M. Giera⁴, M. Foretz⁵, L. Bertrand¹, C. Beauloye¹, S. Horman¹
Abstract Number: PB0442

Acquired Haemophilia A – Data from a Regional Blood Center in Rio de Janeiro, Brazil

P.H.J. Santos¹, M.H. Cerqueira¹, M.M. Loureiro²
Abstract Number: PB0447

Acquired Hemophilia A – Misdiagnosis and Possible Hazards: A Case Report

D. Carneiro-Leão¹, C. Santos¹, J. Sousa Silva², F. Correia¹, S. Nobre Fernandes¹, M. Carvalho¹, M. Lopes¹, C. Koch¹
Abstract Number: PB0449

Acquired Hemophilia A as a Complication of Multiple Myeloma

A. Hoppe¹, J. Rupa-Matysek¹, L. Gil¹
Abstract Number: PB0443

Acquired Hemophilia A Presenting as Spontaneous Intramuscular Hematomas

S. Ahmed¹, E. Joseph¹, K. Loughry¹
Abstract Number: PB0448

Acquired Hemophilia A: Pediatric Case Report

L. Velazquez Marmolejo¹, A.M. Moreno Gonzalez¹, L.M. Munoz Juarez Diaz¹, M.J. Garcia Tevera¹, B.L. Ventura Lopez¹, García Tevera María José, Moreno González Aida Mashenka, Muñoz Juárez Díaz Lucia Mariana, Velázquez Marmolejo Lizette, Ventura López Brenda Lissette.
Abstract Number: PB0446

Acquired Hemophilia after Chemotherapy: Oxaliplatin and Capecitabine, a Case Report

M. Mijares¹, K. Pena¹, L. Carmona¹, V. Vega¹, L. Puente¹, S. Aranda¹
Abstract Number: PB0739

Acquired Isolated FVII Deficiency in Oncological Patients

N. García-León¹, M.T. Calderón-López¹, S. Gómez-Arevalillo Hidalgo¹, P. Martín-Serrano Martín¹, A. Matilla-García¹
Abstract Number: OC 01.4

Acquired Platelet GPVI Signaling Deficiency Occurs Early in Patients with Gram-Positive or Gram-negative Sepsis

L.J. Weiss¹, G. Manukjan¹, M. Weigel¹, N. Winter¹, M. Kredel^2,3, B. Nieswandt^1,4, D. Weismann⁵, H. Schulze¹
Abstract Number: PB0952

Acquired von Willebrand Disease

M. Escobar¹, K. Chong², N. Montanez¹
Abstract Number: PB0804

Acquired von Willebrand Disease in a Child as Leading Symptom of Systemic Lupus Erythematosus

F. Achini-Gutzwiller¹, K. Ruchti¹, G. Spartà¹, K. Ruoss¹, S. Prader¹, J. Pachlopnik Schmid¹, J.A. Kremer², S. Palmer Sarott¹, M. Albisetti¹
Abstract Number: OC 40.2

Acquired von Willebrand Disease in Pediatric Patients Undergoing ECMO Support

J. Drop^1,2, E. Wildschut², M. de Hoog², M. de Maat³, CH. van Ommen¹
Abstract Number: PB0938

Acquired von Willebrand Disease: The Diagnosis and Management of an Underdiagnosed Coagulopathy

A. Ferretti¹, E. Baldacci¹, S. Lancellotti², M. Basso², F. Barone², A. Pallotta³, G. Lapietra¹, M. Sacco², A. Chistolini¹, E. De Candia², C. Santoro¹
Abstract Number: PB0888

Acquired δ-Storage Pool Disorder Co-existing with Acquired Factor V Deficiency in Myelodysplastic Syndrome / Myeloproliferative Neoplasm

R. Dave¹, J. Mammen¹, T. Geevar¹, J. Rasalam¹, R. Vijayan¹, A. Samuel¹, S. Singh¹, S. Nair¹, L. Mathew¹
Abstract Number: LPB0051

ACTIMIS Trial: Safety Interim Analysis Data of Glenzocimab, a Novel Antiplatelet Agent on Top of Acute Ischemic Stroke Standard of Care

M. Mazighi¹, A. Peeters², S. Richard³, C. Molina⁴, R. Lemmens⁵, D. Toni⁶, Y. Plétan⁷, M. Jandrot-Perrus⁸, A. Comenducci⁷, G. Avenard⁷, P. Lyrer⁹, M. Kohrmann¹⁰, ACTIMIS Study Group
Abstract Number: PB0356

Activated charcoal can be used as an effective in vitro removal agent of direct oral anticoagulants dabigatran, rivaroxaban and apixaban in plasma of patients with protein S activity testing

S. Margetić¹, I. Ćelap¹, J. Buben², M. Razum¹, S. Šupraha-Goreta³
Abstract Number: PB1161

Activated Charcoal to Remove DOAC from Patients’ Plasma. Potential Usefulness for Routine Coagulation and Thrombophilia Testing in DOAC Treated Patients

M. Vannini¹, B. Dahmani², A. Appert-Flory¹, F. Fischer¹, D. Jambou¹, P. Toulon¹
Abstract Number: LPB0053

Activated FVIII Inactivation Occurs Outside of the Intrinsic Xase Complex

A. Wilhelm¹, L. George^1,2,3
Abstract Number: LPB0087

Activated Platelets Transfer miR-223 into Endothelial Cells via Microparticles to Downregulate ICAM-1 Expression among Septic Conditions

B. Szilágyi¹, Z. Fejes¹, Á. Rusznyák², F. Fenyvesi², M. Pócsi¹, S. Halmi³, Z. Griger³, S.P. Kunapuli⁴, J. Kappelmayer¹, B. Nagy Jr.¹
Abstract Number: LPB0007

Activated Protein C (APC) Resistance in FV-W1920R (FV-NARA) Was Caused by the Defective Association between FV-W1920R and Protein S (PS) in the APC/PS/FVa Assembly

N. Shimonishi¹, K. Ogiwara¹, J. Yoshida¹, K. Horie¹, K. Nogami¹
Abstract Number: PB0731

Activated Protein C Impacts Survival and Activity of Mast Cells and Neurons via the Modulation of Nuclear Factor-κB Activation

L. Gorbacheva^1,2, A. Ivanova¹
Abstract Number: LPB0017

Activation Mechanism Dependent Surface Exposure of Cellular FXIII on Platelets and Platelet Microparticles: Immunofluorescence and Immune Electron Microscopic Study

L. Somodi¹, H. Bárdos², I. Beke Debreceni³, G. Kis⁴, J. Kappelmayer³, M. Antal⁴, L. Muszbek¹
Abstract Number: LPB0090

Active Cancer and Venous Thromboembolism: Safety and Effectiveness of Edoxaban in Patients from the Noninterventional Global ETNA-VTE Program

A. Cohen¹, M. Nakamura², K.-M. Chiu^3,4, W.-I. Choi⁵, P.-E. Reimitz⁶, W. Jiang⁷, C. Chen⁷, M. Unverdorben⁷, G. Agnelli⁸
Abstract Number: OC 11.3

Active Sorting of Platelets and Red Blood Cells in Contracting Blood Clots is Driven by Platelet-generated Forces that Stiffen Fibrin

V. Tutwiler^1,2, X. Chen¹, R.I. Litvinov^1,3, R. Khismatullin^1,3, J. Kaufmanova¹, C. Nagaswami¹, J.W. Weisel¹, V.B. Shenoy¹
Abstract Number: LPB0031

Activity and Cleavage of von Willebrand Disease Type 2B Variants

M. Brehm¹, Y. Yildiz², T. Obser¹, A. Mojzisch¹, S. Peine³, S. Schneppenheim⁴, U. Budde⁴, R. Schneppenheim⁵
Abstract Number: PB0299

Acute Liver Necrosis in a Sars-Cov-2 Positive Patient with Triple Positive Antiphospholipid Syndrome

V. La Mura^1,2, R. Gualtierotti^1,3, I. Martinelli¹, B. Ferrari¹, A.M. Ierardi⁴, N. Bitto¹, G. Ghigliazza¹, A. Giachi¹, M. Maggioni⁵, M. Cugno^1,3, A.L. Fracanzani^3,6, G. Carrafiello^4,7, F. Peyvandi^1,3
Abstract Number: PB0493

Acute Myelogenous Leukemia in a Patient with Mild Haemophilia A. A Case Report at Hospital Infantil de México Federico Gómez

L.M. Muñoz Juárez Díaz¹, A.M. Moreno Gonzalez¹, L. Velázquez Marmolejo¹
Abstract Number: PB0732

Acute Promyelocytic Leukaemia with Anti Phospholipid Antibody Syndrome – Double Trouble

S.L. Koulmane Laxminarayana¹, S. Belurkar¹
Abstract Number: PB1198

Acute VTE in HIV versus Non-HIV population – Nationwide Analysis of Mortality, Morbidity, Demographics and Healthcare Utilization

M.J. Tariq¹, M.U. Almani¹, J. Tufail², M.A. Elsebaie¹, B. Baral¹, M. Usman¹, S. Gupta¹
Abstract Number: OC 43.4

ADAMTS-13/VWF Ratio as Biomarker for Portal Vein Thrombosis (PVT) Development in Cirrhotic Patients: A Prospective Study

R. De Cristofaro^1,2, M. Sacco², S. Lancellotti¹, M. Tardugno², A. De Magistris³, M. Basso¹, A. Grieco³, M. Pompili³
Abstract Number: PB0088

Adaptation of fixed prothrombin complex concentrate dosing for vitamin K antagonist-related bleeding in the Netherlands

R. Abdoellakhan¹, K. Meijer¹, E. Roelofsen², V. van de Craats³, N. Khorsand⁴
Abstract Number: PB1154

Additional Risk Factors of Hereditary Thrombophilia in the North-Western Region of Russia

V. Soldatenkov¹, O. Soldatenkova¹, N. Mineeva¹, S. Kapustin¹, L. Papayan¹, N. Silina¹, A. Chechetkin¹, K. Komissarov¹
Abstract Number: PB0574

Adherence to Prophylaxis and Recording of Home-treatment Following a Switch to Extended Half-life Clotting Factor Concentrate

M. O'Donovan^1,2, C. Bergine¹, N. Larkin¹, E. Singleton¹, J. Benson¹, F. McGroarty¹, L. Jeffrey³, R. Bird¹, C. Buckley¹, K. Ryan¹, J.S. O'Donnell¹, N.M. O'Connell^1,2
Abstract Number: PB0168

Adjusting D-dimer to Lung Disease Extent to Exclude Pulmonary Embolism in COVID-19 Patients (Co-LEAD)

L. Khider¹, B. Planquette¹, A. Le Berre², S. Soudet³, G. Pernod⁴, R. Le Mao⁵, M. Besutti⁶, N. Gendron¹, A. Yannoutsos², D.M. Smadja¹, G. Goudot¹, T. Mirault¹, E. Messas¹, J. Emmerich², F. Couturaud⁵, G. Ferretti⁴, M.-A. Sevestre³, N. Meneveau⁶, G. Chatellier¹, O. Sanchez¹
Abstract Number: PB0675

Administration of fVIII Protein through Human Placental Cells Reduces the Risk of an Antibody Response in Juvenile Sheep

B. Trevisan¹, M. Rodriguez¹, S. George¹, J. Shields², S. Lankford¹, R. Combs³, M. Gautreaux⁴, J. Owen³, A. Atala¹, C.B. Doering², H.T. Spencer², C.D. Porada¹, MG. Almeida-Porada¹
Abstract Number: PB0530

Adoption of Emicizumab for Hemophilia A in Europe: Data from the 2020 European Association for Haemophilia and Allied Disorders Survey

E. Krumb¹, K. Fijnvandraat², M. Makris³, F. Peyvandi^4,5, A. Ryan⁶, A. Athanasopoulos⁶, C. Hermans¹
Abstract Number: LPB0008

ADP-induced Platelet-associated Tissue Factor Expression: Unique Involvement of the P2Y12 Receptor and Modulation by Clopidogrel Treatment

M. Brambilla¹, P. Canzano¹, G. Rovati², N. Cosentino¹, A. Becchetti¹, J. Campodonico¹, M. Cattaneo³, D. Trabattoni¹, C. Pinna², E. Tremoli¹, M. Camera²
Abstract Number: OC 37.3

Affimers Modulate GPVI Interactions with Collagen/Fibrinogen and GPVI-mediated Platelet Aggregation

R.-G. Xu¹, L.T. Cheah¹, L. Adams², C. Tiede², J.S. Gauer¹, A. Slater³, C. Duval¹, D. Tomlinson², K. Naseem¹, A.B. Herr⁴, S.P. Watson³, R.A.S. Ariëns¹
Abstract Number: PB0270

After the Storm; 6-month Follow up Outcomes and Management of COVID-19 Related Venous Thromboembolism

M. Ahmed¹, R. Khan¹, E. Xenou¹, M. Fowler¹, S. Sinha¹, A. Lokare¹, C. Kartsios¹
Abstract Number: PB0909

Age-specific Changes in von Willebrand Factor Multimers in Healthy Children and Adults

N. Letunica¹, S. Van Den Helm¹, R. Barton^1,2,3, V. Karlaftis^1,2, P. Monagle^3,2,1, V. Ignjatovic^2,1.
Abstract Number: PB0907

Agglomeration and then Capture within 10 ms Creates Shear-induced Platelet Aggregation Controlled by von Willebrand Factor Concentration

Z. Liu¹, C. Bresette¹, C. Aidun¹, D. Ku¹
Abstract Number: PB1179

Agreement between Physician and Nurse Derived Wells Score as Part of the Assessment of Deep Vein Thrombosis in a Rapid Access Ambulatory Clinic

C. Martínez^1,2, B. Rossignol³, M. Zwetkow³, V. Tagalakis^1,4
Abstract Number: OC 33.2

AI_PREMie: A Novel Risk Stratification Tool for Preeclamptic-toxaemia

P.B. Szklanna^1,2, S. Whoriskey³, S. Rajakumar^1,2, J. Curran⁴, B. MacNamee⁵, S.P. Comer^1,2, J. O’Loughlin⁶, C. Murphy^1,7, D. O’Reily^1,6, C. Windrim^8,9, O. Edebiri¹⁰, A. O’Reily^6,11, J. Donnelly^6,11,12, N. O’Gorman^10,13, M. Higgins^8,9, F. Ní Áinle^1,6,10,12, P.B. Maguire^1,2
Abstract Number: PB0623

AKATSUKI Study: A Prospective, Multicenter, Phase IV Study to Evaluate the Safety of Emicizumab Under and Immediately After Immune Tolerance Induction (ITI) Therapy in Persons with Congenital Hemophilia A (PwHA) with Factor (F) VIII Inhibitors

T. Matsushita¹, N. Suzuki¹, A. Nagao², C. Nagae³, H. Yamaguchi-Suita⁴, Y. Kyogoku⁴, A. Ioka⁴, K. Nogami⁵
Abstract Number: LPB0092

Alteration of the Circulating Plasma Proteome by FXa Inhibition in Venous Thromboembolism and the Relationship with Clinical Outcome

A. Pallares Robles¹, V. ten Cate^1,2, A. Schulz², J.H Prochaska^1,2,3, S. Rapp², T. Köck^2,3, S. Heitmeier⁴, S. Schwers⁴, K. Leineweber⁴, H.A. Ghofrani⁵, F.J. Meyer⁶, C. Espinola-Klein⁷, K.J. Lackner^8,3, T. Münzel^7,3,9, S.V. Konstantinides^9,10, P.S. Wild^1,2,3
Abstract Number: PO129

Alterations of the Coagulation Profile in Peruvians Admitted for Pneumonia due to SARS-COV2: Cross-sectional Study

R. Pichardo Rodriguez^1,2, W. Peña-Oscuvilca¹, L. Cordova-Cueva³, O. Ruiz-Franco², F. Garmendia-Lorena²
Abstract Number: PB0082

Altered Hemostasis and Complement in Pediatric Patients Treated with Cardiopulmonary Bypass

K. Todd Jr.¹, J. Tweddell¹, S. Jodele¹, E. Mullins¹, J. Palumbo¹
Abstract Number: PB0820

Altered Hemostatic Potential in Adults with Primary ITP

T. Schramm¹, J. Machacek¹, M. Fillitz², B. Dixer², D. Mehic¹, S. Koder¹, C. Ay¹, I. Pabinger¹, J. Gebhart¹
Abstract Number: OC 15.2

Altered Platelet Proteome and Platelet-leukocyte Interactions in Patients with COVID-19

L. Goudswaard¹, C. Williams¹, F. Hamilton², D. Arnold², A. Davidson¹, A. Poole¹, I. Hers¹
Abstract Number: PB0159

Altered Protein S Activity Contributes Significantly to COVID-19 Pro-thrombotic State

T. Nguyen¹, D. Melancon¹, M. Dean², A. Zea³, S. Chatterjee¹, J. Harman¹, V. Pilli¹, R. Nossaman⁴, J. Ochoa⁴, A. Ochoa², R. Majumder¹
Abstract Number: OC 24.4

Altered vWF-FVIII Binding Modulates the Factor VIII Immune Response

S.M. Zintner¹, R.J. Davidson¹, A.R. Wilhelm¹, R.M. Camire^1,2,3, L.A. George^1,3,2
Abstract Number: LPB0116

An Accurate and Simple Liquid Chromatography Tandem Mass-spectrometric Method for the Quantification of Emicizumab in People with Hemophilia A

A. Donners¹, L. Gerencsér¹, K. van der Elst¹, K. Fischer¹, R. Urbanus¹, M. El Amrani¹
Abstract Number: PB0737

An Assessment of Some Inflammatory and Haemostatic Proteins as Biomarkers for Vaso-occlusive Crises in Sickle Cell Anaemia Patients

O. Izuegbuna¹, I. Durotoye², H. Olawumi², I. Okpala³, K. Ernest²
Abstract Number: NUR 01.1

An Exploration of Venous Thromboembolism (VTE) Prophylaxis Administration Practices across a Hospital Network

J. Chong¹, F. Gad²
Abstract Number: PO178

An Insilco Approach to Venous Thromboembolism (VTE) Using Network Based Medicine with Direct Oral Anticoagulants (DOACs)

A. Khan^1,2, M.J. Khan¹
Abstract Number: LPB0093

An Overall Evaluation of the Adjusted Version of Global Antiphospholipid Syndrome Score (aGAPSS) on Primary Obstetric Antiphospholipid Syndrome (POAPS) Patients

G. de Larrañaga¹, F. Aranda¹, S. Perés Wingeyer¹, S. Udry^1,2, S. Morales Perez³, C. Belizna⁴, J. Alijotas-Reig⁵, E. Esteve-Valverde³, D.S. Fernández Romero², J. Latino²
Abstract Number: PB0999

An Oxidative Stress-induced Platelet-associated Tissue Factor Expression Characterizes Patients with Migraine and Patent Foramen Ovale

P. Canzano¹, D. Trabattoni¹, M. Brambilla¹, B. Porro¹, A. Becchetti¹, S. Fiorelli¹, E. Tremoli¹, M. Camera^1,2
Abstract Number: PB0300

Analysing Risk Factors for Thrombosis in Covid-19 and Cancer Patients

B. Obispo Portero¹, J. Rogado¹, G. Serrano¹, C. Pangua¹, A. Lopez¹, A. Martin¹, M. Perez¹, M.A. Lara¹
Abstract Number: PB0072

Analysis of Coagulation Factors in Fresh-frozen Plasma

M. Pikta^1,2, T. Szanto³, R. Reimal⁴, P. Muliin⁴, H. König⁵, G. Blinova⁵, V. Banys⁶
Abstract Number: PO140

Analysis of Hospitalization Factors of Hemophilia: 12 Years of Experience in a Single Center

C. Qu¹, F. Xue¹, W. Liu¹, L. Chen¹, L. Zhang¹, R. Yang¹
Abstract Number: PB0786

Analysis of Novel Risk Factors for Arterial or Venous Thrombosis in Neonates

K. Bhatia¹, S. Solanki², A.KC Chan³, B. Paes³, M.D Bhatt³
Abstract Number: PO185

Analysis of Risk Factors for Hemorrhagic Complications of Anticoagulant Therapy

N. Vorobyeva^1,2, A. Shchapkov², E. Melnichuk²
Abstract Number: PB0481

Analysis of the Percentage of Persons with Severe Hemophilia A as an Indicator of Care

E. Tootoonchian¹, J. Stonebraker², M. El Ekiaby³, E. Gouider⁴, A. Iorio⁵, M. Makris⁶, J. O'Hara⁷, M. Recht⁸, G. Pierce¹, D. Coffin¹
Abstract Number: PB0385

Analytical Performance of the Novel Haema T4 Thromboelastograph

M. Schoorl¹, T. Jansen¹, J. van Pelt²
Abstract Number: PB0358

Analytical Performances of a New Immunoturbidimetric D-Dimer Assay

L. Talon¹, V. Fourneyron¹, A. Trapani¹, T. Sinegre¹, A. Lebreton^1,2
Abstract Number: PB0204

Anemia and Enhancement of Coagulation Are Associated during Severe COVID-19 Infection

T. Helin¹, M. Lemponen¹, T. Lahtiharju¹, R. Lassila², L. Joutsi-Korhonen¹
Abstract Number: LPB0043

Annexin A2-mediated Surface Fibrinolysis Is Impaired in Non-alcoholic Steatohepatitis (NASH) Cirrhosis and May Contribute to Portal Vein Thrombosis

H.I Lim¹, B. Fortune², M.T DeSancho¹, K.A Hajjar^3,4
Abstract Number: PB1029

Annexin V Binding Detects Platelet Procoagulant Commitment but Is Not Sensitive to Reductions in the Level of Platelet PS Exposure

S. Millington-Burgess¹, M. Harper¹
Abstract Number: PB1294

Antepartum Anemia and Risk of Postpartum Hemorrhage: A Comprehensive Review of the Literature

H. Glonnegger¹, L. Lancaster², R. Barnes², A. von Drygalski^2,3
Abstract Number: PB0135

Anti TFPI for Hemostasis Induction in Patients with Rare Bleeding Disorders, an ex vivo Thrombin Generation (TG) Guided Study

T. Brutman-Barazani¹, E. Avishai¹, I. Budnik², A.A. Barg¹, S. Levi-Mendelovich¹, T. Livnat¹, G. Kenet¹
Abstract Number: OC 53.4

Anti-ADAMTS13 Antibodies in Patients with Hereditary Thrombotic Thrombocytopenic Purpura (hTTP)

S.R. Heeb^1,2, M. Schaller^1,2, E. Tarasco^1,2, J.A. Kremer Hovinga^1,2
Abstract Number: PB0316

Anti-annexinv Serum Levels and Haematological Indices in Sickle Cell Anaemia Patients in Vasooclusive Crisis and Steady States Seen at Lagos University Teaching Hospital Lagos Nigeria

D. Edewor-Okiyo¹, A. Adediran², A. Ogbenna¹, O. Olowoselu¹, A. Omolade³, S. Idogun³
Abstract Number: PB0769

Anti-cancer Activity of Tempeh – Spermine Can Induce the Necrosis of HeLa Cells

H. Sumi¹, T. Mitsuo², C. Yatagai¹
Abstract Number: PB0280

Anti-coagulant Drugs among Moderate, Severe and Critically Ill COVID 19 Patients in the Second Referral Hospital in Surabaya

P.Z. Romadhon¹, S.D. Suryantoro¹, C. Windradi¹, B.A. Mahdi¹, E.D. Agustin¹, D. Novendrianto¹, K.N. Widiastuti¹, M. Savitri¹, P.N.A. Amrita¹, M Noordiansyah¹, S. YB¹, A. Ashariati¹
Abstract Number: OC 66.2

Anti-cysteine/Spacer Autoantibodies that Open the Conformation of ADAMTS13 Are a Common Feature of the Autoimmune Response in Immune-mediated Thrombotic Thrombocytopenic Purpura

L. De Waele¹, A. Curie^1,2, K. Kangro^1,3, E. Tellier⁴, G. Kaplanski^4,5, A. Männik³, C. Tersteeg¹, B.S. Joly⁶, P. Coppo⁷, A. Veyradier⁶, S.F. De Meyer¹, E. Roose¹, K. Vanhoorelbeke¹
Abstract Number: PB0184

Anti-factor Xa Activity after Intermediate Dose Nadroparin for Thrombosis Prophylaxis in Critically Ill COVID-19 Patients with and without Acute Kidney Injury

R. Eck¹, J. van Leur², M. Lukens¹, W. Bult¹, R. Gans¹, K. Meijer¹, F. Keus¹
Abstract Number: PO162

Anti-lymphoma Therapy Improves Thrombocytopenia in a Young Patient with Hodgkin Lymphoma: A Case Report

M. Yang¹, Z. Zhou²
Abstract Number: PB0748

Anti-platelet Drugs and Risk of Intracranial Hemorrhage in Patients with Metastatic Brain Tumors

E. Miller¹, R. Patell², E. Uhlmann³, S. Ren⁴, H. Southard², P. Elavalakanar², G. Weber⁵, D. Neuberg⁴, J. Zwicker²
Abstract Number: OC 70.2

Anti-thrombotics and Anti-hypertensives with Direct Action against SARS-CoV-2

M. Brennan¹, A. Chubb¹
Abstract Number: PB0262

Anticoagulant Response to Tailored Low Molecular Weight Heparin Regimens in Patients with COVID-19 Infection

A. Artoni¹, V. De Zan¹, M. Boscarino¹, C. Novembrino¹, E. Scalambrino¹, S. Aliberti², M. Panigada³, I. Martinelli¹, A. Tripodi¹, F. Peyvandi^1,4
Abstract Number: PB1118

Anticoagulant Therapy and Related Bleeding Complications in Internal Medicine Wards

M.T. Sartori¹, F. Boscaro¹, A. Bozzolin¹, C. Zurlo¹, F. Fabris¹
Abstract Number: PB0370

Anticoagulated Patients Exhibit Intact Endogenous Thrombin Potential Using ST Genesia Unlike the Calibrated Automated Thrombogram

T. Helin¹, M. Lemponen¹, R. Lassila², L. Joutsi-Korhonen¹
Abstract Number: PB0086

Anticoagulation and Antiplatelet Management during the Perioperative Period: A Daily Practice Cohort Prospective Study

O. Duranteau¹, A. Hamriti¹, T. Tuna¹, B. Ickx¹, L. Van Obbergh¹
Abstract Number: NUR 01.6

Anticoagulation Stewardship – Time To Formalize the Role?

V. Silvari¹, A. Delaney¹, C. O'Leary¹, S. McCarthy², D. Lynch¹, M. Crowley¹
Abstract Number: PB0202

Anticoagulation Strategies and Risk Of Bleeding Events in Critically ill COVID-19 Patients

C. Gabara¹, B. Solarat², P. Castro^1,3, S. Fernández^1,3, J.R. Badia², D. Toapanta⁴, S. Schulman⁵, J.C. Reverter⁶, A. Soriano⁷, J. Moises², J. Aibar¹
Abstract Number: PB1244

Anticoagulation Strategies during Conditioning-induced Thrombocytopenia in Hematopoietic Cell Transplant Patients with Venous Thromboembolism

K. Martens¹, C. Amos^2,3, C. Rojas Hernandez⁴, P. Kebriaei⁵, R. Basom⁶, C. Davis⁶, M. Kesten⁶, M. Carrier⁷, D. Garcia⁸, S. Lee^6,9, A. Li^6,10
Abstract Number: PB0230

Anticoagulation with Tinzaparin in COVID-19 Patients in ICU: Are Low Anti-Xa Levels Associated with the Development of Thrombo-embolic Events?

R. Van Lancker¹, S. Demeester², K. Jochmans², M. Mekeirele¹
Abstract Number: PB0728

Antigenic Levels of von Willebrand Factor Predict Complications and Mortality in Patients with Liver Cirrhosis

M. El Horri¹, I. Khachaa¹, A. Cheikh Khelifa¹, A. Berrah¹, M. Baghdadi¹, A. Moueden², D. Benlaldj², F. Seghier²
Abstract Number: PB0998

Antiplatelet Activity Produced by Chloroacilhidroquinones via Inhibition of the Mitochondrial Bioenergy

E. Fuentes¹, D. Méndez¹, I. Palomo¹, M. Alarcón¹, F.A. Urra², A. Trostchansky³, J.P. Millas-Vargas⁴, R. Araya-Maturana⁴
Abstract Number: PB0754

Antiplatelet and Cytostatic Properties of Nilotinib Synthetic Analogues

L.M. Pechlivani¹, N. Ntemou², P. Voulgari², D. Pantazi¹, K. Skobridis², A.D. Tselepis¹
Abstract Number: PB1033

Antiplatelet Effect of Nobiletin Is Mediated by Activation of DP1 Receptor

V. Shpakova¹, A. Avdeeva², S. Gambaryan¹, N. Rukoyatkina¹
Abstract Number: PB1246

Antithrombotic Management of Patients with Deep Vein Thrombosis and Venous Stents: An International Registry

A. Cervi¹, D. Applegate², S.M. Stevens^2,3, S.C. Woller^2,3, L. Baumann Kreuziger⁴, K. Puchhalapalli⁴, T.-F. Wang⁵, R. Lecumberri⁶, S. Schulman^7,8, G. Foster^9,10, J. Douketis¹
Abstract Number: OC 60.2

Antithrombotic Potential of a Single-domain Antibody Enhancing the Anticoagulant Activity of Protein S

J.-C. Sedzro¹, F. Adam¹, A. De Carvalho¹, E. Bianchini¹, I. Peyron¹, S. Gandrille², S. Thomassen³, T.M. Hackeng³, O.D. Christophe¹, P.J. Lenting¹, C.V. Denis¹, D. Borgel^1,4, F. Saller¹
Abstract Number: PB1260

AntiXa Heparin Dosing Protocol Evaluation at a Large Academic Medical Center

T. Ahuja¹, M. Williams¹, S. Arnouk¹, D. Lum¹, J. Papadopoulos¹, V. Raco², D. Green¹
Abstract Number: PB0622

AOZORA Study: Long-Term Safety and Joint Health in Pediatric Patients with Hemophilia A without FVIII Inhibitors Receiving Emicizumab – Protocol for a Multicenter, Open-label, Phase IV Clinical Study

M. Shima¹, H. Takedani², K. Kitsukawa³, M. Taki⁴, A. Ishiguro⁵, A. Nagao⁶, H. Yamaguchi-Suita⁷, Y. Kyogoku⁷, S. Yoshida⁷, K. Nogami¹.
Abstract Number: OC 71.2

Apolipoprotein A-IV Polymorphisms Q360H and T347S Reduce its Inhibitory Effect against Thrombosis

D. MacKeigan^1,2,3, S.-Y. Yu^2,4, A. Shoara⁵, M. Neves^2,3,6,7, P. Chen^2,3,7, C. Shen^2,3,6, P. Bhoria^2,3,6, P. Johnson⁵, H. Ni^1,2,3,6,7,8
Abstract Number: PB0247

Apparent Different of Lupus Anticoagulant Disappearance in Novel Coronavirus 2019 Patients as a Distinct Clinical Feature

H. Kim¹, M.-S. Kim², S. Jang¹
Abstract Number: PB0406

Application of the ISTH-BAT In Congenital Fibrinogen Disorders

S. Mohsenian¹, O. Seidizadeh², A. Azarkeivan¹, M. Jazebi³, S. Moazezi³.
Abstract Number: PB1075

Appropriate dose of Dabigatran in Asian Population

N. Hantrakun¹, W. Wongcharoen¹, K. Thiankhaw¹, L. Norasetthada¹, A. Tantiworawit¹, E. Rattaritamrong¹, T. Rattanathammethee¹, S. Huntrakool¹, P. Piriyakhuntorn¹, C. Chai-Adisaksopha¹
Abstract Number: PB1162

Appropriateness of Thrombophilia Evaluation and Anticoagulation Management: A Multi-specialty Survey of Practitioners at Tower Health Reading Hospital

T. Johnson¹, D. Forman¹
Abstract Number: OC 33.4

Are Antiphospholipid Antibodies a Poor Prognostic Factor for HELLP Syndrome?

M. Pécourt¹, C. Yelnik², L. Ghesquière³, E. Drumez⁴, E. Cailliau⁴, E. Hachulla², V. Debarge³, N. Morel⁵, V. Le Guern⁵, C. Garabedian³, N. Costedoat-Chalumeau⁵, M. Lambert²
Abstract Number: PB0058

Are Direct Oral Anti-Xa Inhibitors Absorbed in Cancer Patients after Gastrectomy? A Case Series

H.C. Puhr¹, A. Ilhan-Mutlu¹, P. Quehenberger¹, P.A. Kyrle¹, S. Eichinger¹, L. Eischer¹
Abstract Number: PB0173

Are Mild or Moderate COVID-19 Patients at Higher Risk of VTE? A Comparison of Two Prospective European Cohorts in Emergency Departments

D. Douillet^1,2, J. Riou^3,4, A. Penaloza⁵, T. Moumneh^1,2, C. Soulié⁶, D. Savary^1,7, F. Morin¹, R. Mahieu^8,9, P.-M. Roy^1,2
Abstract Number: PB0853

Arginine-containing Peptides and Acetylsalicylic Acid: Evaluation of Antiplatelet Effects

M. Grigorjeva¹, T. Obergan¹, T. Shubina¹, L. Lyapina¹
Abstract Number: PB1054

Artificial Intelligence Classifies APS in Anticoagulated Patients Based on Thrombin Generation

R. de Laat-Kremers¹, D. Wahl², S. Zuily², M. Ninivaggi¹, W. Chayoua¹, V. Regnault², J. Musial³, P. de Groot¹, K. Devreese⁴, B. de Laat¹
Abstract Number: PB0249

Artificial Neural Networks to Predict Covid-19 Progression of Moderate Hospitalized Patients using Early Clinical Parameters and Blood Tests

T.D. Martins¹, S.D. Martins², S.A.L. Montalvão², G.Y. Ottaiano¹, M. Al Bannoud¹, L.Q. Silva², S.C. Huber², T.S. Diaz³, C.K. Wroclawski⁴, C.C. Filho⁴, R.M. Filho⁵, J.M. Annichino-Bizzacchi²
Abstract Number: PB0890

Aspirin Resistance after Total Hip or Knee Arthroplasties

N. van Oosterom^1,2, M. Barras^1,2, N. Cottrell¹, R. Bird²
Abstract Number: LPB0072

Aspirin vs P2RY12-Inhibitors to Reduce Cancer Associated Thrombosis and Tumor Growth in Digestive Cancers

A.L. Palacios Acedo¹, S. Mezouar¹, D. Mege^1,2, L. Crescence¹, C. Dubois¹, L. Panicot-Dubois¹
Abstract Number: OC 15.4

Assessing Complement Activation in COVID-19 Predicts Hypoxemia and Mortality

A. Leatherdale^1,2, S. Stukas^3,4, V. Lei^1,2, H. West^1,3, C.J. Campbell⁵, R.L. Hoiland^6,7, J. Cooper^3,4, C.L. Wellington^3,4, M. Sekhon⁸, E.L.G. Pryzdial^1,3,9, E.M. Conway¹
Abstract Number: OC 63.1

Assessing the Clinical Probability of Pulmonary Embolism during Pregnancy: The Pregnancy-Adapted Geneva (PAG) Score

H. Robert-Ebadi¹, A. Elias², O. Sanchez³, E. Le Moigne⁴, J. Schmidt⁵, C. Le Gall⁶, D. Aujesky⁷, P.-M. Roy⁸, T. Moumneh⁹, C. Chauleur¹⁰, F. Rouyer¹¹, G. Le Gal¹², M. Righini¹
Abstract Number: OC 72.3

Assessing the Pharmacodynamics of RUC-4 (Zalunfiban), a Novel αIIbβ3 Antagonist, Using VerifyNow Assays in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Treated with Aspirin and Ticagrelor

O.S. Bentur¹, W.L. Bor², K.L. Zheng², A.H. Tavenier³, A. van ’t Hof⁴, J.M. ten Berg^2,4, B.S. Coller¹
Abstract Number: PB1227

Assessing Use of Surrogate Outcome Measures in Randomized Controlled Trials Investigating Venous Thromboembolism Prophylaxis

A. Eshaghpour¹, A. Li², J. Park³, T. Cho³, M. Crowther⁴
Abstract Number: PB0421

Assessment of DOACs Effect on Clot Formation and Fibrinolysis Using the FibWave

J. Evrard¹, V. Maloteau¹, J.M. Dogné¹, J. Douxfils²
Abstract Number: PB0384

Assessment of Low Response Rates to P2Y12 Inhibition in Cardiology Patients: Comparison of the VerifyNow P2Y12 and Anysis-P2Y12 Assay

S. Shin¹, J. Piao¹, Y.-W. Whang², C.U. Choi².
Abstract Number: PB0349

Assessment of Sample Stability after Freezing on ST Genesia System Using the STG-BleedScreen Application

J. Mullins¹, D. White¹, A. Carlo², S. Cox-Morton¹, S. Mac Donald¹
Abstract Number: PB0528

Assessment of the Bleeding Phenotype in Patients with Non-severe Hemophilia According to the ISTH Bleeding Assessment Tool (BAT)

F. Kloosterman¹, A. Zwagemaker¹, S.C. Gouw^1,2, C.N. Bagot³, P. Brons⁴, M. Cnossen⁵, P. Collins⁶, S. Jackson⁷, K. Meijer⁸, M.J.H.A. Kruip⁹, F.W.G. Leebeek⁹, B. Laros-van Gorkom¹⁰, C. Male¹¹, I. Pabinger¹², S. Shapiro¹³, M. Coppens¹⁴, J.G. van der Bom¹⁵, K. Fijnvandraat^1,16, DYNAMO Study Group
Abstract Number: PB0989

Assessment of the Effects of Syk and BTK Inhibitors on GPVI-mediated Platelet Signaling and Function

T. Zheng¹, E. Lofurno², A. Melrose¹, H. Lakshmanan¹, J. Pang¹, K. Phillips³, M. Fallon¹, T. Kohs¹, A. Ngo¹, J. Shatzel¹, M. Hinds¹, O. McCarty¹, J. Aslan¹
Abstract Number: PB1309

Assessment of the Utility of the Pregnancy-adapted YEARS Algorithm in Predicting Presence of Pulmonary Embolism (PE) in Pregnant Women (PA-PE)

A. Alexander¹, E. Treharne¹, E. jackson¹, B. Myers²
Abstract Number: PB0592

Assessment of Thrombin Generation on Severe Haemophilia A Patients in the Clinical Laboratory

J. Mullins¹, D. White¹, S. Cox-Morton¹, A. Marin², M. Gironella², F. Bosch², S. Franco², A. Tosetto³, S. Mac Donald¹
Abstract Number: PB0417

Assessment of Сardiometabolic Biomarkers in Young Adults with Normal Body Weight and Obesity

V. Chulkov¹, E. Gavrilova¹, V. Chulkov¹, N. Vereina¹, S. Sinitsin¹, S. Martynov¹, P. Tkachenko¹, E. Lenets¹
Abstract Number: PB0868

Assigning Pathogenicity to a Novel de Novo ACTN1 Variant in a Child with Macrothrombocytopenia: A Case Description And Review of Previously Identified Variants

L. FitzGibbon¹, V. Bouskill², M. Carcao², L. Li³, F.G Pluthero³, W.H. Kahr^2,3,4, S.K Westbury^1,3
Abstract Number: PO125

Associated Factors of Adherence to the Use of Coumarin Derivatives or Direct Oral Anticoagulants: Protocol of a Systematic Review

W. Sousa^1,2, N. Guimarães¹, C. Viana¹, P. Machado¹, A. Medeiros^1,3, M. Vianna¹, M.A. Martins^1,2,3
Abstract Number: PB1101

Association between Cancer and Anatomical Site of Venous Thromboembolic Disease

D. Froehling¹, W. Wysokinski¹, R. McBane¹, D. Houghton¹, D. Vlazny¹, D. Hodge², L. Peterson¹, A. Casanegra¹
Abstract Number: PB1193

Association between Cardiovascular Risk Factors and Venous Thrombosis in the Elderly

H. Wang¹, M. Cushman², F.R Rosendaal¹, A. van Hylckama Vlieg¹
Abstract Number: PB0476

Association between Factor VIII Deficiency and Low Bone Mineral Density in Children with Hemophilia

O.U. Galindo-Aguilar¹, P.A. García-Hernández², J.Á. Garza³, D. Garay-Mendoza⁴, M. Ortiz-Castillo⁵, A. González-Martínez⁵, A.J. Bautista-Gómez⁵, G. González-Martínez⁵, J.F. Molina-de la Garza⁵, L. Villarreal Martínez⁵
Abstract Number: PO127

Association between FGB – 455 G/A and PAI-1 – 675 5G / 4G Gene Polymorphisms and Covid-19 Severity

B. Vatseba¹, N. Virstyuk¹
Abstract Number: LPB0142

Association between Non-O Blood Group and the Risk of Venous Thromboembolism due to Oral Contraceptive Therapy

A. Poretto¹, L. Spiezia¹, G. Turatti¹, M. Marobin¹, E. Borella¹, E. Campello¹, D. Tormene¹, P. Simioni¹
Abstract Number: LPB0048

Association between Plaque Vulnerability and Neutrophil Extracellular Traps (NETs) Levels: The Plaque at RISK Study

J.J. de Vries¹, A.S. Autar¹, D.H. van Dam-Nolen¹, S.J. Donkel¹, M. Kassem², A.G. van der Kolk^3,4, T.J. van Velzen⁵, ME. Kooi², J. Hendrikse⁴, P.J. Nederkoorn⁵, D. Bos¹, A. van der Lugt¹, M.P. de Maat¹, H.M. van Beusekom¹
Abstract Number: PB0271

Association between Race and the Incidence of Thrombosis in Hospitalized COVID-19 Patients Across a New York City Hospital System

P.P. Theprungsirikul¹, S.E. Saith¹
Abstract Number: PB1240

Association of Adding Antiplatelet Therapy to Warfarin for Management of Venous Thromboembolism with Bleeding and Other Adverse Events

M. Song¹, B. Haymart¹, X. Kong¹, M. Ali², J. Kozlowski³, G. Krol⁴, S. Kaatz⁴, J. Froehlich¹, G. Barnes¹
Abstract Number: OC 06.4

Association of Anticoagulation Resumption and Repeat Imaging on Venous Thromboembolism Recurrence after Allogeneic Hematopoietic Cell Transplantation (HCT)

K. Martens¹, C. Amos^2,3, C. Rojas Hernandez⁴, P. Kebriaei⁵, R. Basom⁶, C. Davis⁶, M. Kesten⁶, M. Carrier⁷, D. Garcia⁸, S. Lee^6,9, A. Li^6,10
Abstract Number: PO189

Association of Complete Blood Parameters, D-dimer and Lupus Anticoagulant with VTE Risk Score in Hospitalized Patients

E. Ezigbo¹, I. Isiwu², L. Nnamani², T. Nwagha³
Abstract Number: PB0256

Association of Elevated D-dimers with Severity and Outcome of Covid-19 Infection in Children

N. Saqlain¹, N. Mazher¹, A. Bari¹, A. Ch¹, S. Farhan¹, N. Ahmed¹
Abstract Number: LPB0139

Association of FXI Activity with Thrombo-inflammation, Extracellular Matrix Interactions, Lipid Metabolism and Apoptosis in Venous Thromboembolism

A. Pallares Robles¹, V. ten Cate^1,2, A. Schulz², J.H. Prochaska^1,2,3, S. Rapp², T. Köck^2,3, M. Panova Noeva^1,2, S. Heitmeier⁴, S. Schwers⁴, K. Leineweber⁴, H.-J. Seyfarth⁵, C.F. Opitz⁶, H. Spronk⁷, C. Espinola-Klein⁸, K.J. Lackner^9,3, T. Münzel^8,3,10, M.A. Andrade-Navarro¹¹, S.V. Konstantinides^10,12, H. ten Cate⁷, P.S. Wild^1,2,3
Abstract Number: OC 13.3

Association of Genetic Alterations with Severity of Disease in Type III vWD Patients

M.A. Naveed¹, S. Khaliq¹, S. Mohsin¹, A. Abid², U. Saleem³, A. Ammar¹
Abstract Number: PB0616

Association of Individual Pharmacokinetics-guided Regimen in Hemophilia A Patients and FVIII Consumption: A Single-center Study

Q. Hong¹, C. Shu Qin¹, Z. Wen Jing², H. Xiao Hua³, C. Yong Fang¹, Y. Yu Hua¹, X. Xing Yi⁴
Abstract Number: PB1098

Association of KRAS Mutation with Arterial Thromboembolism in Advanced Lung and Gastrointestinal Cancer

S. Maharaj¹, S. Bhandari¹, X. Wu¹, S. Rai¹, V. Sharma¹
Abstract Number: PB0512

Association of Physical Activity with Bleeding Frequency in Children with Hemophilia A: A CHESS PAEDs Study Analysis

R. Ofori-Asenso¹, F. Nissen², M. Silkey², T. Xu², H. Yamaguchi-Suita³, D. Nosaka³, M. Aizenas², O. Meier², T. Burke^4,5, J. O'Hara^4,5
Abstract Number: PB0753

Association of Platelet Count and Coagulopathy before, during and Post Chemotherapy: Is it Worth Doing?

N. Anwar¹, N. Fatima¹, H.-u. Mujtaba¹, T. Shamsi¹
Abstract Number: PB1069

Association of Retest Interval with INR Control in Warfarin Patients with Markedly Out of Range INRs

B. Haymart¹, X. Kong¹, G.D Barnes¹, A. Purohit¹, M. Ali², E. Kline-Rogers¹, J.H Kozlowski³, G. Krol⁴, V. Shah⁴, J.B Froehlich¹, S. Kaatz⁴
Abstract Number: OC 76.2

Association of Single Nucleotide Polymorphisms with Major Bleeding Risk during Vitamin K Antagonists Treatment: A Case-cohort Study

E. Camilleri¹, M.H.A. Bos^2,3, P.H. Reitsma^2,3, F.J.M. van der Meer², J. Swenn⁴, S.C. Cannegieter^1,2,3, N. van Rein^4,5
Abstract Number: PB0144

Association of the Angiopoietin/Tie2 and VEGF-A Pathways with clinical and Laboratory Markers of Disease Severity in COVID-19

C.R.P. Moraes¹, F. Lima¹, I.T. Borba Junior¹, M.S. Barbosa¹, L.C Ribeiro¹, A.C Palma¹, R.G Ulaf¹, A.F. Bernardes¹, E. Mansour¹, F.T.M. Costa², F.A. Orsi¹, J.M Annichino-Bizzacchi^1,3, M.L. Moretti¹, L.A Velloso^1,4, E.V. De Paula^1,3
Abstract Number: OC 64.3

Associations of Residual Venous Obstruction, d-Dimers, fFctor VIII and CRP with Long-term Outcomes of Deep Vein Thrombosis

A.F. Iding^1,2, B. Kremers², A. Pallares Robles^2,3, M. Pavlicic¹, H. ten Cate^1,2,4, A.J. ten Cate-Hoek^1,2
Abstract Number: PB0193

Atherothrombotic Events in Hospitalized COVID-19 Patients Are Associated with Diabetes mellitus

D. Morozova¹, K. Nezhdanov¹, O. Eliseeva², L. Minushkina³, D. Zateyshchikov³
Abstract Number: PB0107

Atrial Flutter and Intracardiac Thrombus After Cardiac Surgery

S. Karaman¹, D. Gokceer Karabulut², A. Unuvar¹, S. Sahin¹, K. Nisli², D. Tugcu¹, G. Tanyildiz¹, R. Tuna¹, M. Bilici¹, Z. Karakaş¹
Abstract Number: PB0943

Atypical Presentation of VWD Leading to Discovery of Novel VWF Mutation

T. van de Berg¹, A.M Todaro¹, J. van Beers², K. Wichapong¹, F. Heubel-Moenen³, E. Castoldi¹, Y. Henskens², E. Beckers³
Abstract Number: PB0828

Autoimmune Platelet Function Disorders: Systematic Review of Acquired Glanzmann Thrombasthenia and Acquired Delta Storage Pool Disease Cases

A. Ferretti¹, M. Bacci², M. Marchetti³, M.A. Alberelli¹, A. Falanga⁴, C. Lodigiani⁵, E. De Candia⁶
Abstract Number: PB1064

Automated Methods for the Enhancement of Lupus Anticoagulant Mixing Study Sensitivities

Z. Cao¹, R. Bottenus¹, C. Kung¹